Insulet (PODD) earnings per share (EPS)

Earnings per share · fiscal 2025
$3.48

Insulet (PODD) reported diluted earnings per share of $3.48 in fiscal 2025 (the year ended December 31, 2025). That is 39.8% lower than the $5.78 of fiscal 2024. Figures as of 17 Nov 2026, 21:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$3.48
Change on fiscal 2024
−39.8%
Growth, 5 years
+103.4% a year
Highest on record
$5.78fiscal 2024
Lowest on record
-$0.48fiscal 2016
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Insulet earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 103.4% a year. Across the 10 fiscal years on record (2016–2025), the highest was $5.78 in fiscal 2024 and the lowest -$0.48 in fiscal 2016.

History · 10 fiscal years

Earnings per share by fiscal year

Insulet earnings per share (EPS), year by year

Insulet (PODD) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$3.48 39.8% down
2024$5.78 96.6% up
2023$2.94 4,100.0% up
2022$0.07 70.8% down
2021$0.24 140.0% up
2020$0.10 47.4% down
2019$0.19 280.0% up
2018$0.05—
2017-$0.46—
2016-$0.48—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Insulet and comparable companies
CompanyEarnings per shareFiscal year
Vaxcyte PCVX-$5.632025
Bio-Rad Laboratories BIO$27.852025
Molina Healthcare MOH$8.922025
Spyre Therapeutics SYRE-$1.982025
Qiagen QGEN$2.042025
Insulet PODD$3.482025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PODD

Insulet, figure by figure

Insulet (PODD) overview: price, valuation and scorecardAll health care companies by market value

Insulet earnings per share (EPS): questions and answers

What is Insulet's diluted earnings per share?

Insulet (PODD) reported diluted earnings per share of $3.48 in fiscal 2025 (the year ended December 31, 2025). That is 39.8% lower than the $5.78 of fiscal 2024.

What is the growth rate of Insulet's diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 103.4% a year.

What are the highest and lowest diluted earnings per share figures on record for Insulet?

Across the 10 fiscal years on record (2016–2025), the highest was $5.78 in fiscal 2024 and the lowest -$0.48 in fiscal 2016.

How is Insulet's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Insulet (PODD) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/PODD/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.